Fritzberg A R, Klingensmith W C, Whitney W P, Kuni C C
J Nucl Med. 1981 Mar;22(3):258-63.
The tetradentate chelating agent N,N'-bis(benzoylmercaptoacetamido)ethylenediamine was synthesized for evaluation as a potential technetium-99m renal-function radiopharmaceutical. Complexes were prepared using different reducing agents and analyzed by high-performance liquid chromatography. Biological studies were performed in mice, rats, and rabbits and indicated that the new agent is cleared by the kidneys significantly faster than Tc-99m DTPA (p less than 0.01) and slightly slower than I-131 o-iodohippuric acid (p greater than 0.05). There was no evidence of significant renal retention. Renal excretion in all species studied was 70--75% of the injected dose in 30 min; biliary excretion in rats was 7% in animals with normal renal function and 18% in 90 min in the absence of renal function. We conclude that limited clinical trials are warranted.
合成了四齿螯合剂N,N'-双(苯甲酰巯基乙酰胺基)乙二胺,以评估其作为一种潜在的锝-99m肾功能放射性药物的性能。使用不同的还原剂制备配合物,并通过高效液相色谱法进行分析。在小鼠、大鼠和兔子身上进行了生物学研究,结果表明,这种新药物在肾脏中的清除速度明显快于锝-99m二乙三胺五乙酸(p<0.01),略慢于碘-131邻碘马尿酸(p>0.05)。没有明显肾脏潴留的证据。在所有研究物种中,30分钟内肾脏排泄量为注射剂量的70%-75%;在肾功能正常的大鼠中,胆汁排泄量为7%,在无肾功能的大鼠中,90分钟内胆汁排泄量为18%。我们得出结论,有必要进行有限的临床试验。